Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:06:39 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Q:DMAC - DIAMEDICA THERAPEUTICS INC - http://www.diamedica.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DMAC - Q0.12.30·2.810.12.57+0.041.67.8171022.51  2.59  2.49434.75  1.5316:00:14Apr 1715 min RT 2¢

Recent Trades - Last 10 of 102
Time ETExPriceChangeVolume
16:00:14Q2.580.0510
16:00:02Q2.580.057
16:00:02Q2.580.051
16:00:02Q2.580.055
16:00:02Q2.580.055
16:00:02Q2.580.055
16:00:02Q2.580.055
16:00:02Q2.580.055
16:00:02Q2.580.055
16:00:02Q2.580.055

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-17 16:08U:DMACNews ReleaseDiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
2024-04-04 16:30U:DMACSEDAR Annual ReportSEDAR Annual Report
2024-03-19 17:51U:DMACSEDAR Annual ReportSEDAR Annual Report
2024-03-19 17:44U:DMACSEDAR Audited Annual Financial StatementsSEDAR MD & A
2024-03-19 16:15U:DMACNews ReleaseDiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
2024-01-29 16:13U:DMACNews ReleaseDiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference
2024-01-22 08:23U:DMACNews ReleaseDiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer
2023-11-13 19:42U:DMACSEDAR Interim MD & ASEDAR Interim MD & A
2023-11-13 19:41U:DMACSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-13 16:28U:DMACNews ReleaseDiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
2023-11-09 08:25U:DMACNews ReleaseDiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023
2023-11-06 08:23U:DMACNews ReleaseDiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023
2023-09-12 08:13U:DMACNews ReleaseDiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer
2023-09-06 08:35U:DMACNews ReleaseDiaMedica Therapeutics to Participate at Lake Street ¢ € ™s 7th Annual Best Ideas Growth Conference
2023-08-14 17:07U:DMACSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-14 16:13U:DMACNews ReleaseDiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results
2023-08-08 08:32U:DMACNews ReleaseDiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023
2023-07-18 11:27U:DMACSEDAR Early Warning ReportSEDAR Early Warning Report
2023-07-18 08:30U:DMACNews ReleaseDiaMedica Therapeutics to Attend the American Academy of Neurology Summer Conference
2023-07-11 14:51U:DMACSEDAR Final ProspectusSEDAR Final Prospectus